December 1, 2022
November 30, 2022
November 29, 2022
December 5, 2022
December 2, 2022
November 30, 2022
Researchers from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI) have been studying ways to uncover potential new drug therapies for the common and lethal brain cancer, glioblastoma. In a new study, the team discovered that […]
November 23, 2022
Many will also face barriers to care, where access to specialists is limited and often geographically out of reach. That’s where technology coupled with user-centred design can help – bringing solutions and convenience to these pain points and positively impacting […]
November 16, 2022
Babies born via cesarean section may not mount as strong an immune response after some childhood vaccines compared to babies delivered vaginally, researchers suggest. Antibody levels can be checked in blood or saliva, and babies born vaginally had higher levels […]
Clinical Trials, Research and Development
December 1, 2022
GENScientists at the University of Pennsylvania say they have developed a novel optical method that uses a pair of macromolecular phosphorescent probes for the real-time monitoring of cerebral metabolic rate of oxygen consumption (CMRO2), concurrently with cerebral blood flow (CBF) […]
November 30, 2022
PharmaphorumFollowing a consultation with the US Food and Drug Administration (FDA), and in accordance with the requirements of the FDA’s Accelerated Approval Program, Genentech has chosen to withdraw the US indication of atezolizumab for the treatment of adults with locally […]
Clinical Trials, Research and Development
November 30, 2022
PharmaphorumWHIM syndrome is a rare, inherited, combined immunodeficiency disease that inhibits the body’s ability to fight infections. In most patients, this is caused by over-signalling of the CXCR4/CXCL12 pathway, resulting in reduced mobilisation and trafficking of white blood cells from […]
Clinical Trials, Research and Development
November 30, 2022
GENThe results of research headed by a team at Shanghai Jiao Tong University have identified formic acid as a sensitive urinary biomarker that can reveal early-stage Alzheimer’s disease (AD). The findings could potentially pave the way for inexpensive and convenient […]
Cell and Gene Therapy, Industry
November 29, 2022
Biopharma DiveOnce a fringe area of cancer research, cell therapy has exploded over the last decade. Since 2017, several treatments have come to market for blood cancers like leukemia and multiple myeloma, establishing cell therapy as a new class of medicines. […]
Clinical Trials, Research and Development
November 29, 2022
GENAs far as emerging, zoonotic, viruses go—Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is one to watch. The disease, which is endemic in Africa, the Balkans, the Middle East, and some Asian countries, is considered a priority pathogen by the World Health […]
November 29, 2022
GENResearchers at the Perelman School of Medicine at the University of Pennsylvania have developed an experimental multivalent mRNA-based vaccine against all 20 known subtypes of influenza virus. Their approach differs from previous attempts to craft a universal flu vaccine, by […]
December 5, 2022
November 7, 2022
November 7, 2022
November 29, 2022
November 17, 2022
November 15, 2022
Copyright © 2022. All rights reserved
